Table 16 An assessment of the changes in necropsy findings affected by the 90-day oral administration of 23%-GNANA, a test substance to the male and female rats (n=10)
Organs | Observed signs | Groups (mg/kg/day)a) |
G1 (0)% | G2 (1,250) | G3 (2,500) | G4 (5,000) |
Male | Female | Male | Female | Male | Female | Male | Female |
Thymus | Redness | 1 | | 1 | | 0 | | 0 | |
Testis(R) | Aatropy | 0 | | 0 | | 0 | | 1 | |
Uterus | Retention of clear fluid | | 0 | | 0 | | 0 | | 2 |
Adrenal(R) | Aatropy | | 0 | | 0 | | 0 | | 1 |
No. of animals | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
%: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High-dose group (G4: 5,000 mg/10 mL/day)